AAU universities conduct a majority of the federally funded university research that contributes to our economic competitiveness, health and well-being, and national security. AAU universities are growing our economy through invention and innovation while preparing the next generation of scientists and engineers for global leadership. By moving research into the marketplace AAU universities are helping to create jobs, and provide society with new medicines and technologies.
A study by researchers at Duke University School of Medicine found that supplying healthy mitochrondra to damaged nerve cells can signifantly help millions managing pain from diabetic neuropathy and chemotherapy.
Researchers from the USF College of Marine Science are studying soft tissue samples from barnacles, oysters, and fish to better understand the state of contamination and its origins in Tampa Bay, Florida's largest estuary.
The advancement lays the groundwork for creating a library of sugar-recognizing proteins that may help detect and treat diverse illnesses.
The olfactory senses of ants help them hunt, detect outsiders, and know their role within a colony. In a new study, researchers have discovered how ants can switch one gene on out of hundreds to ensure their survival.
Explore More: University Research
You can filter stories by the university.
Researchers at Northwestern have developed a novel wearable device to catch early signs and symptoms associated with COVID-19
A team of researchers has developed a portable, more environmentally friendly method to produce hydrogen peroxide. It could enable hospitals to make their own supply of the disinfectant on demand and at lower cost.
Armed with a rapid response research grant from the National Science Foundation, University of Oregon biologist Stilianos Louca is mining public databases for genomic and associated data being filed on the coronavirus that causes COVID-19.
A nasal spray derived from algae and a plant in the tobacco family could offer a preventive measure for COVID-19, per Pitt researchers.
Researchers at University of California San Diego School of Medicine have launched a clinical trial to investigate whether a drug approved for treating high blood pressure, heart failure and diabetic kidney disease might also reduce the severity of COVID-19 infections, lowering rates for intensive care unit admissions, the use of mechanical ventilators and all-cause mortality.